The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,771.50
Bid: 1,771.00
Ask: 1,771.50
Change: 10.50 (0.60%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,775.50
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: RSA rises amid heavy volume on bid talk

Wed, 23rd Oct 2013 14:06

Chip designer ARM Holdings fell for the second straight day as investors gave a cool reaction to its third-quarter results. JPMorgan Cazenove said this morning that it sees "no reason to be building positions at this time and would take profits in the short term". A number of stocks were also trading in the red after going ex-dividend, including Smiths Group, BAE System, Rolls-Royce, John Menzies, Senior, William Hill, Rank Group, Barratt Developments and JD Wetherspoon.Banks all over Europe were out of favour after the European Central Bank said it would start to review the balance sheets of 130 institutions across the continent. RBS, Barclays, Lloyds, and HSBC were all registering losses in London.HSBC was also likely affected by the news its subsidiary HSBC Bank Middle East (HBME) has terminated the sale agreement of its banking business in Pakistan to JS Bank because regulatory approval was not received.GlaxoSmithKline beat earnings growth expectations in the third quarter but the share price fell after revenues came in 2% below expectations. With turnover up 1% to £6.51bn during the three months to September 30th, the drug developer lifted core operating profits 11% to £2.06bn at constant exchange rates (CER) and earnings per share 16% to 28.9p at CER.Meanwhile, renewed takeover speculation pushed RSA Insurance shares higher. Reuters referenced trader talk that Swiss-listed Zurich Financial, Italy-based Generali and UK peer Aviva are all being touted as potential bidders for the company - in a transaction whose value may rise to £7bn. Housebuilders Persimmon and Travis Perkins were given a lift by the British Bankers' Association which reported that the number of mortgages approved last month surged by almost 40% above last year's September figure to 42,990. FTSE 100 - RisersRSA Insurance Group (RSA) 129.00p +4.12%United Utilities Group (UU.) 718.50p +1.91%International Consolidated Airlines Group SA (CDI) (IAG) 365.50p +1.81%Travis Perkins (TPK) 1,814.00p +1.80%Persimmon (PSN) 1,247.00p +1.63%Associated British Foods (ABF) 2,101.00p +1.45%Legal & General Group (LGEN) 212.60p +1.24%Shire Plc (SHP) 2,524.00p +1.24%Resolution Ltd. (RSL) 351.70p +1.24%SABMiller (SAB) 3,225.00p +1.22%FTSE 100 - FallersSmiths Group (SMIN) 1,391.00p -4.40%Anglo American (AAL) 1,508.50p -3.05%Antofagasta (ANTO) 877.00p -2.99%Royal Bank of Scotland Group (RBS) 353.80p -2.27%Rio Tinto (RIO) 3,196.00p -2.01%Barclays (BARC) 267.20p -1.98%GlaxoSmithKline (GSK) 1,570.50p -1.91%CRH (CRH) 1,516.00p -1.88%HSBC Holdings (HSBA) 676.10p -1.69%ARM Holdings (ARM) 987.00p -1.69%NR
More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.